Apolipoprotein E (apoE) is a 34-kDa resident of lipoproteins that plays a key role in cholesterol homeostasis in plasma and in brain. It is composed of an N-terminal (NT) domain (residues 1-191) and a C-terminal (CT) domain (residues 201-299). Of the three major isoforms (apoE2, -E3, and -E4), apoE4 is considered a risk factor for both cardiovascular and Alzheimer disease. Compared with apoE3, domain interaction between NT and CT domains is believed to direct the lipoprotein distribution preference of apoE4 for very low density lipoprotein-sized particles. We examined the relative disposition of apoE4 NT and CT domains in lipid-free and lipid-bound forms by monitoring pyrene excimer fluorescence emission as a direct indicator of spatial proximity. Site-specific labeling of apoE4 by N-(1-pyrene)maleimide was accomplished after substitution of Cys residues for Arg-61 in NT domain and Glu-255 in CT domain. Pyrene labeling did not alter the lipoprotein distribution pattern of apoE4 in plasma. Pyrene excimer fluorescence was noted in lipid-free pyrene-R61C/E255C/apoE4 in mixtures containing excess wildtype apoE4, which was attributed to intramolecular spatial proximity between these specified sites. Upon disruption of tertiary interaction, a large decrease in excimer fluorescence emission was noted in pyrene-R61C/ E255C/apoE4. In dimyristoylphosphatidylcholine/pyrene-R61C/E255C/apoE4 discoidal complexes, pyrene excimer fluorescence emission was retained. Taken together with fluorescence quenching and cross-linking analysis, a looped-back model of apoE4 is proposed in lipid-bound state, including spherical lipoprotein particles, wherein residues Arg-61 and Glu-255 are proximal to one another.
Apolipoprotein E (apoE)1 belongs to the super family of exchangeable apolipoproteins that are major constituents of lipoproteins (1). It plays a crucial role in lipid homeostasis, not only in the plasma but also in the brain. ApoE exerts a protective effect against development of atherosclerosis (2, 3) by promoting cellular uptake (4) and clearance of triglyceride-rich lipoproteins from blood (5, 6). In addition, apoE in macrophages has a direct antiatherogenic effect independent of alterations in plasma lipoproteins (7) by promoting cholesterol efflux (8) from cell lining of arteries by a process termed reverse cholesterol transport (9 -11). The role of apoE in cholesterol homeostasis in the brain is emerging with evidence of its protective role against neuronal injury and neurodegeneration (12).In humans, apoE displays polymorphism with three major genetic variants identified in the population, apo⑀2, -⑀3, and -⑀4, with allelic frequencies of 8%, 77%, and 14%, respectively, determining six apoE phenotypes, apoE2/E2, apoE3/E3, apoE4/ E4, apoE2/E3, apoE2/E4, and apoE3/E4 (13). The apoE isoforms determine the atherogenic fate of the lipoproteins on which they reside. Although the apoE2 isoform is associated with type III hyperlipoproteinemia, peripheral atherosclerosis, and accumulation of remnant lipoproteins, apoE4 is consistent...